Peginterferon and ribavirin for hepatitis C.
Ben Salem
Chaker
C
Hmouda
Houssem
H
Bouraoui
Kamel
K
D000998:Antiviral Agents / Q000009:adverse effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D010195:Pancreatitis / Q000139:chemically induced*; D011092:Polyethylene Glycols / Q000009:adverse effects; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin